This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes.
Reviews in endocrine & metabolic disorders, 23(5), 979-994
Citation
Aroda, Vanita R; Blonde, Lawrence; Pratley, Richard E. (2022). A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes.. Reviews in endocrine & metabolic disorders, 23(5), 979-994. https://doi.org/10.1007/s11154-022-09735-8